(Q24203634)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

23 January 2020

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

L E Satkunam

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Dan Deforge

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

15 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

CD004156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Objective quantification of spastic hypertonia: correlation with clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Onset, natural history and outcome in idiopathic adult motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Anti-spasticity agents for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

Trial of Baclofen in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Protirelin tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Pendulum testing of spasticity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

The value of muscle exercise in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Intrathecal baclofen for severe spinal spasticity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

Familial adult motor neuron disease: amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004156.PUB4

7 January 2021

10.1002/14651858.CD004156.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22336799%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference